相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy
Yang Yang et al.
BLOOD (2007)
Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress
Crescent R. Isham et al.
BLOOD (2007)
Nontoxic proteasorne inhibition activates a protective antioxidant defense response in endothelial cells
Silke Meiners et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
Progressively impaired proteasomal capacity during terminal plasma cell differentiation
S Cenci et al.
EMBO JOURNAL (2006)
Coordination of ER and oxidative stress signaling: The PERK/Nrf2 signaling pathway
SB Cullinan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells.
W Zou et al.
CLINICAL CANCER RESEARCH (2006)
MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells costimulates pamidronate-activated γδ lymphocytes
S Girlanda et al.
CANCER RESEARCH (2005)
Sulindac enhances the proteasome inhibitor bortezomib-mediated oxidative stress and anticancer activity
T Minami et al.
CLINICAL CANCER RESEARCH (2005)
Selective induction of the tumor marker glutathione S-transferase P1 by proteasome inhibitors
H Usami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phosphorylation of the α-subunit of the eukaryotic initiation factor-2 (eIF2α) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition
HY Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Translational control in stress and apoptosis
M Holcik et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity
K van Leyen et al.
JOURNAL OF NEUROCHEMISTRY (2005)
The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance
D Chauhan et al.
BLOOD (2004)
XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation
AL Shaffer et al.
IMMUNITY (2004)
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors
XY Pei et al.
CLINICAL CANCER RESEARCH (2004)
Proteasome inhibitor PS-341 induces a apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells
A Fribley et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Two enzymes in one: Two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function
HH Jang et al.
CELL (2004)
Strategies for reversing drug resistance
T Fojo et al.
ONCOGENE (2003)
Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival
SB Cullinan et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells
D Chauhan et al.
ONCOGENE (2003)
Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells
YH Ling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells
AH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1
NN Iwakoshi et al.
NATURE IMMUNOLOGY (2003)
An integrated stress response regulates amino acid metabolism and resistance to oxidative stress
HP Harding et al.
MOLECULAR CELL (2003)
The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction
Q Chen et al.
CELL DEATH AND DIFFERENTIATION (2003)
Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion
E van Anken et al.
IMMUNITY (2003)
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
N Mitsiades et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2
KR Sekhar et al.
ONCOGENE (2002)
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
MH Glickman et al.
PHYSIOLOGICAL REVIEWS (2002)
Chronic B cell malignancies and bone marrow microenvironment
P Ghia et al.
SEMINARS IN CANCER BIOLOGY (2002)
Syndecan-1 in B lymphoid malignancies
RD Sanderson et al.
ANNALS OF HEMATOLOGY (2002)
Plasma cell differentiation requires the transcription factor XBP-1
AM Reimold et al.
NATURE (2001)
Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein - Implication for heme oxygenase-1 gene regulation
CH He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of antioxidant metabolism by translation initiation factor 2α
S Tan et al.
JOURNAL OF CELL BIOLOGY (2001)
分享论文
